molecules-logo

Journal Browser

Journal Browser

Small Molecules Targeting Age-Related Diseases

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 31 March 2026 | Viewed by 59

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126 Pisa, Italy
Interests: hydrogen sulfide (H2S); cardiovascular system; ageing; potassium channels; mitochondria
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi 13, 56124 Pisa, Italy
Interests: organic chemistry; catalyst; synthesis; organometallics; heterocyclic chemistry; catalysis

Special Issue Information

Dear Colleagues, 

In 2024, the World Health Organization announced that “By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million”.  

It is known that elderly people can be affected, more easily, by chronic diseases, negatively impacting their quality of life and increasing the associated personal and socioeconomical burdens; thus, the treatment and prevention of age-related diseases has become essential in ensuring a healthy lifestyle. Several cellular targets have been identified, including the sirtuins family, and are currently being investigated as a topic of natural as well as synthetic-derived small molecules. In this scenario, the aim of this Special Issue entitled “Small Molecules Targeting Age-Related Diseases” is to collect the more recent results about the application of isolated molecules or extracts obtained from the natural kingdom, but also the synthesis and application of small molecules, even natural-inspired ones, in the prevention and treatment of age-related pathologies, like cardiovascular, neurodegenerative, and metabolic diseases. 

We invite contributions of original studies or reviews from the literature on (1) providing insights into the cellular and molecular mechanisms of action of well-known molecules, (2) evaluating  the effectiveness of small molecules in not-yet-considered age-related diseases, and (3) proving the development of original small molecules, even those obtained from natural sources to improve their pharmacokinetic or pharmacodynamic properties.  

Dr. Lara Testai
Dr. Marco Lessi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • age-related diseases
  • small molecules
  • cardiovascular diseases
  • neurodegenerative diseases
  • metabolic disorders

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop